Robuta

A new Finnish study from University of Turku shows that already a 30-minute exercise can increase the proportion of tumor-killing white blood cells in the...

By assessing how 'sticky' tumor cells are, researchers have found a potential way to predict whether a patient's early-stage breast cancer is likely to spread....

Switches that colorectal cancer cells use to migrate away from the primary tumor site and to invade neighboring tissue have been found by researchers. This...

The retinoblastoma protein inhibits cancer by controlling cell division. Now, researchers have shown that it also binds to and inhibits genes necessary for...

scientific article published on October 1982

The global circulating tumor cells market size was evaluated at USD 14.68 billion in 2025 and is predicted to hit around USD 54.76 billion by 2035, growing at...

A new study shows that tumors not only evade the immune system but can actively reprogram immune cells to stop fighting.

Single-cell sequencing of bone marrow epithelial-like cells, in parallel with intra-tumor genetic heterogeneity profiling from bulk DNA, is a powerful approach...

Tumor angiogenesis requires intricate regulation of gene expression in endothelial cells. We recently showed that DNA methyltransferase (DNMT) and histone...

In the last decades cancer has been considered as an epigenetic dysfunction, given the profound role of diet and lifestyle in cancer prevention and the...

scientific article published on February 1, 1979

scientific article published on December 1977

As the expression of a tumor associated antigen (TAA) is commonly not restricted to tumor cells, adoptively transferred T cells modified to express a...

A molecular probe has been developed that emits light at critical stages while destroying tumor cells.

Spatial oxidation of L-plastin downmodulates actin-based functions of tumor cells. by Emre Balta, Robert Hardt, Jie Liang, Henning Kirchgessner, Christian...

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to new...

Our study reveals a novel mechanism by which HBV-DNA-Pol promotes HCC by controlling glycogen metabolism in HCC, establishing a direct link between HBV-DNA-Pol...

Octamer-binding transcription factor 4 (Oct4) has been recently implicated as a proangiogenic regulator in several induced pluripotent stem cells (iPSCs), ho...

scientific article published on May 1991

Researchers may have found a new way to promote immune cell attack on tumors. When faced with cancer, the immune system dispatches cells, called T cells, to...

Medical physicists at the University of Virginia have created a novel way to kill tumor cells using nanoparticles and light. The technique, devised by Wensha...

Tumors are complex tissues of cancerous cells surrounded by a heterogeneous cellular microenvironment with which they interact. Single-cell sequencing enables...

p38 blockage has been shown to increase the death of tumor cells, thus causing tumors to shrink. The combination of p38 inhibitors with chemotherapeutic drugs...

There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However, these...

A prospective 'PARP inhibitor' drug that has struggled to show effectiveness in clinical trials against cancers can be structurally modified to greatly...